WHO ARE WE

Pioneers in Hair Follicle Regeneration through Autologous Micrografts

About Regenera
Activa Worldwide

Made in Europe, part of the Remedi Group, Regenera Activa AMT is a leading biotech brand specializing in hair folicle regeneration through regenerative medicine with the patented Rigenera® technology. Founded in 2014, the company has rapidly become an authority in the field, leveraging innovative approaches to combat androgenetic alopecia.

Regenera Activa holds numerous European and international certifications, reflecting its commitment to the highest standards of quality and safety. Over 10,000 doctors worldwide have performed more than 450,000 successful procedures, significantly improving the lives of those affected by AGA.

The patented Rigenera® technology is the first and original method of its kind, and the only proven solution on the market for obtaining the AMT® Triad. This unique autologous and tissue-specific micrograft suspension contains progenitor cells, human smart exosomes, and extracellular matrix, unlocking the body's innate healing capabilities for advanced regenerative results.

About Regenera <br>Activa Worldwide

Our Journey

Years of Innovation, Scientific Research, and Global Expansion

2006

Dr. Graziano and Dr. D’Aquino were involved in the field of scientific research in Naples. They realized that from a simple filtering work it is possible to improve biological performance of the tissue and, therefore, its ability to intrinsic healing.

2012

Human Brain Wave is founded in Italy for the fabrication and distribution of Rigenera®

2013

First prototype of Rigenera® is tested in the Italian market in Odontology and Wound Healing field.

2014

Rigenera® technology is patented and the first Autologous Micrografting Technology® protocols with use of Rigenera® are developed. Human Brain Wave and Regenera Activa start working together for the Italian and Spanish market. 

2015

Rigenera® Emergency Kit is launched for military and civilian emergencies. Also, it is selected as a part of RAWINTS (Rapid Wounding Healing) project financed by NATO.

2016

Regenera Activa begins its expansion in the European, Asian and South American markets. The Protocol on Hair Restoration is implemented.

2017

Regenera Activa expands to new countries and consolidates in current markets. The novel AMT® Protocol on Orthopaedics & SRT with Rigenera® technology is developed

2018

Regenera Activa expands exponentially through Asia.

2019

Regenera Activa starts contracts with Middle East area and Australia, while expands its Traumatology line with new distributors in Spain and South America.

2020

Regenera Activa launched the Cosmeceutical pack line. Also, amidst the COVID-19 crisis Regenera Activa started its digitalization opening multiple channels in social media and offering high-interest international webinars.

2021

Regenera Activa shares the AMT® Protocol on Hair Transplant to enhance the results and efficiency of the surgery. 

2022

Regenera Activa continues its expansion, with global KOLs talking about their experience using AMT® protocols for different applications all over the world.  Regenera Activa participated with Dr. Antonella Tosti in her “Full Hair Immersion” course in Mexico. Regenera Activa presented a scientific study together with Dr. Antonella Tosti and Dr. Colombina at the First Barcelona Hair Meeting Congress in Sitges.